PD
The startup develops an EHR data analysis platform that utilizes machine learning algorithms to identify symptomatic patients based on specific phenotypes for clinical trials. This technology enhances the recruitment process for drug testing, enabling researchers to efficiently target and examine new treatments on suitable candidates.
Updated 18 months ago
Funding
$4.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops an EHR data analysis platform that utilizes machine learning algorithms to identify symptomatic patients based on specific phenotypes for clinical trials. This technology enhances the recruitment process for drug testing, enabling researchers to efficiently target and examine new treatments on suitable candidates.